NewsResearch
NELSON lung screening trial: What the Lung Cancer Trial Found
NELSON screened current and former smokers with low-dose CT and measured nodules by volume rather than width. Fewer men died of lung cancer, and only 2.1% were sent for further investigation.
Original commentary from the Cancer Explained editorial team.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
This one is about screening, not treatment
Every other landmark trial on this site asks what to do about a cancer someone already has. NELSON asks a different kind of question: does looking for lung cancer in people who feel well save lives, and at what cost in false alarms?
Who was screened, and how often
13,195 men made up the main analysis group. A smaller group of 2,594 women was studied separately. All were aged 50 to 74, and all were current or former smokers. They lived in the Netherlands and Belgium.
Half were assigned to low-dose CT scans at the start and then at years 1, 3 and 5.5. The other half had no screening. Everyone was followed for at least ten years, using national registries to record cancers and deaths.
Adherence among the men was 90.0%, which is unusually high for a screening trial.
Measuring nodules by volume, not width
Most screening programmes measure a nodule's diameter on a scan. NELSON measured its volume, and how fast that volume grew between scans.
The difference matters. A small nodule that is not growing can be watched instead of investigated. That is how NELSON kept its referral rate to 2.1% of participants. On average, 9.2% of screened people had at least one extra CT because a first result was unclear, but most stopped there.
Fewer lung cancer deaths among the men
Over ten years, there were 2.50 lung cancer deaths per 1,000 person-years in the screened group and 3.30 in the unscreened group. The cumulative rate ratio was 0.76 (95% CI 0.61 to 0.94; P=0.01) — about 24% fewer deaths from lung cancer.
More lung cancers were found in the screened group: 5.58 cases per 1,000 person-years against 4.91. That is expected when you look harder. The point of screening is that finding them earlier changes what happens next.
The women's result
Among women, the rate ratio was 0.67 (95% CI 0.38 to 1.14). The direction is the same and the size looks larger. But the confidence interval crosses 1, so the result is not statistically significant. That is a matter of numbers, not biology: only 2,594 women took part, against 13,195 men.
What this does not mean for you
- It does not show that screening helps people who have never smoked. Everyone here had a smoking history.
- It does not settle the question for women. That group was too small to answer it.
- The low false-alarm rate depends on the volume-based protocol. A programme that measures diameter and refers on size alone should expect more unnecessary tests.
- Participants were Dutch and Belgian. Access, follow-up and treatment differ elsewhere.
Questions about lung screening
- Do I meet the age and smoking criteria used where I live?
- How does this centre measure and follow up nodules?
- What happens if a scan finds something unclear?
- What is the radiation dose across a full round of screening?
Sources
This article was written from the sources below, which were checked on the source-check date shown above.
How this article was prepared
Prepared by Cancer Explained's AI-assisted editorial system and checked against the sources listed below. This article has not been reviewed by a healthcare professional unless a named reviewer is specifically shown.
Cancer Explained is published by the National Cancer Information Foundation as a nonprofit-oriented public-interest education project. It is not a diagnostic service, does not recommend treatments, and is not for emergencies.
Found an error, a broken source link, outdated information, or wording that feels insensitive? Report it here — we log and act on material corrections.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to Lung cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
Learn about this story’s cancer topic
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.